Retrospective Study
Copyright ©The Author(s) 2025.
World J Psychiatry. Jul 19, 2025; 15(7): 103684
Published online Jul 19, 2025. doi: 10.5498/wjp.v15.i7.103684
Table 1 Baseline characteristics
Parameters
Control group (n = 153)
Intervention group (n = 161)
t/χ2
P value
Age (year), mean ± SD27.25 ± 2.1727.36 ± 2.610.4160.678
BMI (kg/m2), mean ± SD23.68 ± 2.7423.71 ± 2.830.0840.933
Marital status (married/other)149 (97.39)/4 (2.61)151 (93.79)/10 (6.21)2.3820.123
Educational level0.5550.758
Junior high school51 (33.33)48 (29.81)
High school and vocational school42 (27.45)49 (30.43)
College and above60 (39.22)64 (39.75)
Smoker6 (3.92) 8 (4.97)0.2020.653
Household income (monthly)0.0710.965
< 10000 RMB38 (24.84)39 (24.22)
10000-20000 RMB78 (50.98)81 (50.31)
> 20000 RMB37 (24.18)41 (25.47)
Compliance122 (79.74)133 (82.61)0.4240.515
Nulliparous105 (68.63)115 (71.43)0.2930.588
Infant sex (male/female)70 (45.75)77 (47.83)0.1360.713
Any breastfeeding146 (95.42)157 (97.52)1.0140.314
All preterm deliveries (< 37 weeks)13 (8.50)9 (5.59)1.0170.313
PPROM9 (5.88)4 (2.48)2.2820.131
Major postpartum hemorrhage8 (5.23)4 (2.48)1.6070.205
GDM36 (23.53)21 (13.04)5.8060.016
Severe nausea and vomiting24 (15.69)19 (11.80)1.0020.317
Gestational hypertension14 (9.15)6 (3.73)3.8690.049
Preeclampsia6 (3.92)4 (2.48)0.1630.687
Chronic hypertension with superimposed preeclampsia5 (3.27)2 (1.24)0.6940.405
Zung self-rating depression scale45.75 ± 4.2645.37 ± 4.650.750.454
Table 2 Comparison of baseline biomarkers before intervention between the two groups
Variable
Control group (n = 153)
Intervention group (n = 161)
t
P value
Folate (nmol/L)25.37 ± 3.1224.79 ± 3.461.5580.12
Homocysteine (μmol/L)7.31 ± 1.177.28 ± 1.340.1700.865
Riboflavin (nmol/L)8.78 ± 2.048.52 ± 1.971.1760.241
FMN (nmol/L)12.08 ± 2.5712.41 ± 2.391.1640.245
Inositol (μmol/L)16.27 ± 3.2415.98 ± 3.610.7570.449
Calcium (mg/dL)9.12 ± 1.069.23 ± 1.120.9320.352
Iron (μg/dL)92.17 ± 10.2593.74 ± 9.761.3910.165
Zinc (μg/dL)86.33 ± 6.1986.04 ± 7.180.3780.706
Probiotics (CFU × 108/g)92.37 ± 16.1593.25 ± 17.240.4650.642
Table 3 Comparison of biomarkers between the two groups 1 week before delivery
Variable
Control group (n = 153)
Intervention group (n = 161)
t
P value
Folate (nmol/L)42.28 ± 5.3742.69 ± 3.460.8010.424
Homocysteine (μmol/L)3.95 ± 1.033.94 ± 1.140.0630.95
Riboflavin (nmol/L)16.31 ± 3.6717.08 ± 4.281.7090.088
FMN (nmol/L)10.35 ± 2.0710.39 ± 2.340.1540.877
Inositol (μmol/L)21.28 ± 4.7122.37 ± 3.452.3260.021
Calcium (mg/dL)9.66 ± 2.1410.15 ± 2.271.9620.051
Iron (μg/dL)107.34 ± 12.28111.35 ± 10.283.1300.002
Zinc (μg/dL)91.74 ± 9.3495.34 ± 10.813.1560.002
Probiotics (CFU × 108/g)95.34 ± 15.2799.64 ± 16.272.4130.016
Table 4 Comparison of baseline mood scale scores before the intervention between the two groups
Variable
Control group (n = 153)
Intervention group (n = 161)
t
P value
PANAS-NOW
PA12.35 ± 2.3612.64 ± 2.611.0480.296
NA27.36 ± 3.1527.42 ± 3.620.1660.868
STAI
State anxiety67.65 ± 10.2569.47 ± 9.711.6140.108
Trait anxiety71.34 ± 8.1872.35 ± 8.021.1120.267
PHQ-89.44 ± 2.889.52 ± 3.010.2410.81
Table 5 Comparison of baseline World Health Organization Quality of life Assessment: Brief Version scores before intervention between the two groups
Variable
Control group (n = 153)
Intervention group (n = 161)
t
P value
Physical health45.68 ± 6.8446.12 ± 6.720.5690.570
Psychological33.13 ± 6.7733.65 ± 7.110.6610.509
Social relationships42.25 ± 7.1241.98 ± 7.620.3220.748
Environment43.66 ± 7.8742.97 ± 8.120.7620.446
Table 6 Comparison of basic neonatal conditions at birth between the two groups
Variable
Control group (n = 153)
Intervention group (n = 161)
t/χ2
P value
Gestational age at birth39.42 ± 1.2339.15 ± 1.092.1110.036
Birth weight (kg)3.18 ± 0.513.28 ± 0.521.7140.088
Body length (cm)49.25 ± 1.3549.71 ± 1.562.8200.005
Head circumference35.14 ± 2.3634.57 ± 2.811.9450.053
Placental weight (g)541.55 ± 15.82540.19 ± 17.520.7210.472
Placental area (cm2)175.69 ± 17.64174.74 ± 16.780.4920.623
Umbilical cord length (cm)55.12 ± 17.8557.36 ± 18.941.0740.284
Admission to neonatal unit, n (%)12 (7.84)4 (2.48)4.6580.031
Neonatal septicemia, n (%)2 (1.31)0 (0)0.5560.456